EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and TSHR Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer

Mintaute Kazlauskiene iD, Raimonda Klimaite iD, Aiste Kondrotiene iD, Albertas Dauksa, Dalia Dauksiene, Rasa Verkauskiene, Birute Zilaitiene iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mintaute Kazlauskiene und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Cancer, Papillary, DNA Methylation, Thyroid Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lithuanian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the expression of microRNAs (miRNAs) -146b-3p, -221-5p, -222-3p, and -21a-3p and the methylation pattern of the thyroid-stimulating hormone receptor (TSHR) gene in blood plasma samples from papillary thyroid cancer (PTC) patients before and after thyroidectomy compared to healthy controls (HCs). This study included 103 participants, 46 PTC patients and 57 HCs, matched for gender and age. Significantly higher preoperative expression levels of miRNAs and TSHR methylation were determined in the PTC patients compared to HCs. Post-surgery, there was a notable decrease in these biomarkers. Elevated TSHR methylation was linked to larger tumor sizes and lymphovascular invasion, while increased miRNA-222-3p levels correlated with multifocality. Receiver operating characteristic (ROC) analysis showed AUCs below 0.8 for all candidate biomarkers. However, significant changes in the expression of all analyzed miRNAs and TSHR methylation levels indicate their potential to differentiate PTC patients from healthy individuals. These findings suggest that miRNAs and TSHR methylation levels may serve as candidate biomarkers for early diagnosis and monitoring of PTC, with the potential to distinguish PTC patients from healthy individuals. Further research is needed to validate these biomarkers for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsThyroid Cancer, PapillaryDNA MethylationThyroid NeoplasmsBiomarkers, TumorReceptors, ThyrotropinGene Expression Regulation, NeoplasticHumansFemaleMaleMiddle AgedAdultCase-Control StudiesROC Curve

Stichwörter der Autor:innen

TSHR methylationmiRNA-146b-3pmiRNA-21a-3pmiRNA-221-5pmiRNA-222-3ppapillary thyroid cancerplasma samples

Substanzen

MicroRNAsBiomarkers, TumorReceptors, ThyrotropinMIRN146 microRNA, humanMIR222, humanMIR221, humanMIRN21 microRNA, human

Autor:innen und Institutionen

  • Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.
  • Institute of Digestive Research, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.

ORCID-Profile: Mintaute Kazlauskiene, Raimonda Klimaite, Aiste Kondrotiene, Birute Zilaitiene

Förderung

  • Lithuanian Research Council

Zitieren

APA

Kazlauskiene, M., Klimaite, R., Kondrotiene, A., Dauksa, A., Dauksiene, D., Verkauskiene, R., & Zilaitiene, B. (2024). Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and TSHR Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158412

Vancouver

Kazlauskiene M, Klimaite R, Kondrotiene A, Dauksa A, Dauksiene D, Verkauskiene R, et al. Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and TSHR Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158412

BibTeX
@article{Kazlauskiene2024,
  author = {Kazlauskiene, Mintaute and Klimaite, Raimonda and Kondrotiene, Aiste and Dauksa, Albertas and Dauksiene, Dalia and Verkauskiene, Rasa and Zilaitiene, Birute},
  title = {Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and TSHR Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158412}
}
Kostenlos starten →